Aril Frydén

4.5k total citations · 1 hit paper
83 papers, 2.9k citations indexed

About

Aril Frydén is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Aril Frydén has authored 83 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 36 papers in Hepatology and 14 papers in Rheumatology. Recurrent topics in Aril Frydén's work include Hepatitis C virus research (28 papers), Liver Disease Diagnosis and Treatment (26 papers) and Hepatitis B Virus Studies (21 papers). Aril Frydén is often cited by papers focused on Hepatitis C virus research (28 papers), Liver Disease Diagnosis and Treatment (26 papers) and Hepatitis B Virus Studies (21 papers). Aril Frydén collaborates with scholars based in Sweden, United Kingdom and United States. Aril Frydén's co-authors include Ola Weiland, Gunnar Norkrans, Ulla Foberg, Hans Link, Rune Wejstål, Olle Reichard, Robert Schvarcz, Ulrik Mathiesen, G. Bodemar and L Franzén and has published in prestigious journals such as The Lancet, Hepatology and Neurology.

In The Last Decade

Aril Frydén

81 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS

1984 412 citations Aril Frydén et al. profile →

Peers

Countries citing papers authored by Aril Frydén

Since Specialization

Citations

This map shows the geographic impact of Aril Frydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aril Frydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aril Frydén more than expected).

Fields of papers citing papers by Aril Frydén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aril Frydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aril Frydén. The network helps show where Aril Frydén may publish in the future.

Co-authorship network of co-authors of Aril Frydén

This figure shows the co-authorship network connecting the top 25 collaborators of Aril Frydén. A scholar is included among the top collaborators of Aril Frydén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aril Frydén. Aril Frydén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health-related quality of life in patients with different stages of liver disease induced by hepatitis C 2009 ·Scandinavian Journal of Gastroenterology ·Einar Björnsson, Hans Verbaan, Antti Oksanen, Aril Frydén, Jonas Johansson, (unknown), Olav Dalgård, Evangelos Kalaitzakis	52
2	Nosocomial hepatitis C in a thoracic surgery unit; retrospective findings generating a prospective study 2008 ·Journal of Hospital Infection ·Kristina Cardell, Anders Widell, Aril Frydén, Britt Åkerlind, (unknown), Stefan Franzén, (unknown), B. Isaksson	5
3	Excellent Response Rate to a Double Dose of the Combined Hepatitis A and B Vaccine in Previous Nonresponders to Hepatitis B Vaccine 2008 ·The Journal of Infectious Diseases ·Kristina Cardell, Britt Åkerlind, Matti Sällberg, Aril Frydén	68
4	Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases 2002 ·Digestive and Liver Disease ·Ulrik Mathiesen, L Franzén, (unknown), (unknown), Lars Jacobsson, Ulla Foberg, Aril Frydén, G. Bodemar	295
5	High Serum Hepatocyte Growth Factor Levels in the Acute Stage of Community-acquired Infectious Diseases 2002 ·Scandinavian Journal of Infectious Diseases ·Fariba Nayeri, Ingela Nilsson, Lars Brudin, Aril Frydén, (unknown), P. Forsberg	19
6	Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon 1999 ·Journal of Hepatology ·Olle Reichard, (unknown), Aril Frydén, Gunnar Norkrans, Rune Wejstål, Ola Weiland	120
7	GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors 1998 ·Journal of Medical Virology ·Steven Shev, Per Björkman, Gunnar Norkrans, Ulla Foberg, Aril Frydén, Gudrun Lindh, Annika Lindholm, Ola Weiland, Anders Widell	22
8	Hepatitis C Virus Transmission, 1988–1991, via Blood Components from Donors Subsequently Found to be Anti-HCV-positive 1996 ·Scandinavian Journal of Infectious Diseases ·Ulla Foberg, Bengt Ekermo, Anders Widell, Ulrik Mathiesen, Aril Frydén	19
9	RESULTS OF A PLACEBO-CONTROLLED STUDY OF RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS-C 1994 ·UCL Discovery (University College London) ·Geoffrey Dusheiko, Ola Weiland, (unknown), Olle Reichard, (unknown), (unknown), Aril Frydén, Hendrik W. Reesink, (unknown), Gunnar Norkrans, (unknown), (unknown), (unknown), Paul Telfer, (unknown), (unknown), (unknown)	6
10	Long-term Findings in Patients with Facial Palsy and Antibodies against Borrelia burgdorferi 1994 ·Scandinavian Journal of Infectious Diseases ·(unknown), Pia Forsberg, Aril Frydén, B Hederstedt, Dag Hydén, Lars Ödkvist	5
11	Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications 1994 ·Journal of Medical Virology ·Anders Widell, Steven Shev, (unknown), (unknown), Ulla Foberg, Gunnar Norkrans, Aril Frydén, Ola Weiland, Jan Kurkus, Erik Nordenfelt	101
12	Second‐Generation Hepatitis C Elisa Antibody Tests Confirmed by the Four‐Antigen Recombinant Immunoblot Assay Correlate Well with Hepatitis C Viremia and Chronic Liver Disease in Swedish Blood Donors 1993 ·Vox Sanguinis ·Steven Shev, Ulla Foberg, Aril Frydén, Svante Hermodsson, Gudrun Lindh, A Lindholm, (unknown), Madeleine von Sydow, Ola Weiland, (unknown), (unknown)	19
13	Acute “idiopathic” peripheral facial palsy: Clinical, serological, and cerebrospinal fluid findings and effects of corticosteroids 1993 ·American Journal of Otolaryngology ·Dag Hydén, (unknown), P. Forsberg, E Fridell, Aril Frydén, Annika Linde, Lars Ödkvist	30
14	Empirical modelling versus commonly applied data analysis techniques as used for decision support in liver diseases 1992 ·(unknown), (unknown), Ulrik Mathiesen, Lennart Franzén, Ulla Foberg, Aril Frydén, G. Bodemar, Ove Wigertz	2
15	Sulfur Amino Acid Metabolism in Hepatobiliary Disorders 1992 ·Scandinavian Journal of Gastroenterology ·Jerker Mårtensson, Ulla Foberg, Aril Frydén, Morton K. Schwartz, Bo Sörbo, Ola Weiland	12
16	Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B/C hepatitis: Long-term outcome and effect of increased interferon doses in non-responders 1991 ·Scandinavian Journal of Infectious Diseases ·Robert Schvarcz, Hans Glaumann, Ola Weiland, Gunnar Norkrans, Rune Wejstål, Aril Frydén	15
17	Viral haemorrhagic fever in Sweden: Experiences from management of a case 1991 ·Scandinavian Journal of Infectious Diseases ·Ulla Foberg, Aril Frydén, Barbro Isaksson, Peter B. Jahrling, A. Johnson, Kelly T. McKee, Bo Niklasson, (unknown), C. J. Peters, Mats Bengtsson	11
18	Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience 1990 ·Journal of Hepatology ·Ola Weiland, Robert Schvarcz, Rune Wejstål, Gunnar Norkrans, Aril Frydén	56
19	A Randomized Controlled Open Study of Interferon Alpha-2b Treatment of Chronic IMon-A, Non-B Posttransfusion Hepatitis: No Correlation of Outcome to Presence of Hepatitis C Virus Antibodies 1989 ·Scandinavian Journal of Infectious Diseases ·Robert Schvarcz, Ola Weiland, Rune Wejstål, Gunnar Norkrans, Aril Frydén, Ulla Foberg	63
20	A Clinical and Epidemiological Study of “Ornithosis” Caused by Chlamydia psittaci and Chlamydia pneumoniae (Strain TWAR) 1989 ·Scandinavian Journal of Infectious Diseases ·Aril Frydén, Erik Kihlström, Rolf Maller, Kenneth Persson, Victoria Romanus, S Ånséhn	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact